 Bank of New York Mellon Corp cut its stake in Five Prime Therapeutics Inc NASDAQ:FPRX by 18.1 in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission SEC. The institutional investor owned 129,354 shares of the biotechnology companys stock after selling 28,591 shares during the period. Bank ... 